This is a routine proxy notice with no material financial or operational news. The proposed 1,500,000 share increase to the equity plan is modest for a $13M market cap company and is standard practice. Monitor the actual vote outcome and any subsequent 8-K for dilution details, but no immediate trading action is warranted.
Price Chart
Executive Summary
Phio Pharmaceuticals Corp. filed a DEFA14A (additional definitive proxy soliciting materials) for its 2026 Annual Meeting of Stockholders to be held on September 28, 2026. The filing is a routine notice providing instructions for accessing proxy materials and voting online, with the Board recommending votes FOR all six director nominees, ratification of Grant Thornton as auditor, and approval of a 1,500,000 share increase to the 2020 Long Term Incentive Plan. No financial results, activist activity, or material corporate events are disclosed.
Key Facts
- Annual Meeting scheduled for September 28, 2026, held virtually.
- Record date for voting is August 4, 2026.
- Board recommends FOR election of six director nominees: Robert J. Bitterman, Patricia A. Bradford, David H. Deming, Jonathan E. Freeman, Curtis A. Lockshin, and R. Todd Plott.
- Board recommends FOR ratification of Grant Thornton, LLP as independent auditor for FY 2026.
- Board recommends FOR amendment to 2020 Long Term Incentive Plan to increase shares available by 1,500,000.
- Filing is a routine DEFA14A notice; no financial data or material events reported.
Financial Impact
No financial figures reported in this filing.
Risk Factors
- Potential dilution from 1,500,000 share increase to the equity plan, though amount is small relative to market cap.
- No financial or operational updates in this filing; risk of negative news at the meeting or in future filings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001683168-26-006474 |
| Document: 0001683168-26-006474-index-headers.html | 0001683168-26-006474 |
| Document: 0001683168-26-006474-index.html | 0001683168-26-006474 |
| Document: 0001683168-26-006474.txt | 0001683168-26-006474 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 8-K | $1.03 $1.01 | ▼ −1.94% | ▼ −2.05% | $1.00 (−2.91%) |
Aug 14, 2026 6w ago | DEFA14A | $1.06 $1.17 | ▲ +10.38% | ▲ +11.57% | $1.00 (−5.66%) |
Apr 8, 2026 25w ago | 8-K | $1.25 $1.27 | ▲ +1.60% | ▼ −1.59% | $1.00 (−20.00%) |
Apr 8, 2026 25w ago | 424B5 | $1.25 $1.27 | ▲ +1.60% | ▼ −1.59% | $1.00 (−20.00%) |
Mar 5, 2026 30w ago | 8-K | $1.16 $1.17 | ▲ +0.86% | ▲ +2.39% | $1.00 (−13.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access